FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:358-359 August 1, 2002 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Kenchaiah, S. PubMed Citation

As has been noted repeatedly by expert panels and the lay press, nearly 60 percent of the adult population of the United States is overweight or obese, with substantial resulting morbidity and mortality.¹ Since obesity increases the risk of the most frequent causes of heart failure, an association between these conditions is to be expected. Indeed, an increased risk of heart failure has previously been noted in the Framingham Heart Study and in other cohort studies.^2,3,4 However, controversy has persisted with regard to whether obesity is an independent risk factor for heart failure or even coronary heart disease. For instance, . . . [Full Text of this Article]

Related Letters:

Obesity and the Risk of Heart Failure
O'Brien G., Maurer M. S., Taegtmeyer H., Wilson C. R., Dart R. A., Jenny-Avital E. R., Kenchaiah S., Levy D., Vasan R. S., Massie B. M.
Extract | Full Text | PDF  
N Engl J Med 2002; 347:1887-1889, Dec 5, 2002. Correspondence

This article has been cited by other articles:

• Lee, S.-D., Kuo, W.-W., Bau, D.-T., Ko, F.-Y., Wu, F.-L., Kuo, C.-H., Tsai, F.-J., Wang, P. S., Lu, M.-C., Huang, C.-Y. (2008). The coexistence of nocturnal sustained hypoxia and obesity additively increases cardiac apoptosis. J. Appl. Physiol. 104: 1144-1153 [Abstract] [Full Text]  
• Lamounier-Zepter, V., Ehrhart-Bornstein, M., Karczewski, P., Haase, H., Bornstein, S. R., Morano, I. (2006). Human adipocytes attenuate cardiomyocyte contraction: characterization of an adipocyte-derived negative inotropic activity. FASEB J. 20: 1653-1659 [Abstract] [Full Text]  
• Brotman, D. J., Walker, E., Lauer, M. S., O'Brien, R. G. (2005). In Search of Fewer Independent Risk Factors. Arch Intern Med 165: 138-145 [Abstract] [Full Text]  
• Mariotti, R., Castrogiovanni, F., Becherini, F., Cortese, B., Rondinini, L., Mariani, M. (2004). Obesity, weight loss and heart failure. Eur Heart J Suppl 6: F87-F90 [Abstract] [Full Text]  
• Mehra, M. R., Uber, P. A., Park, M. H., Scott, R. L., Ventura, H. O., Harris, B. C., Frohlich, E. D. (2004). Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 43: 1590-1595 [Abstract] [Full Text]  
• Cheng, A. Y., Fantus, I G. (2004). Thiazolidinedione-Induced Congestive Heart Failure. The Annals of Pharmacotherapy 38: 817-820 [Abstract] [Full Text]  
• Rehman, J., Considine, R. V., Bovenkerk, J. E., Li, J., Slavens, C. A., Jones, R. M., March, K. L. (2003). Obesity is associated with increased levels of circulating hepatocyte growth factor. J Am Coll Cardiol 41: 1408-1413 [Abstract] [Full Text]  
• Keller, K. B., Lemberg, L. (2003). Obesity and the Metabolic Syndrome. Am J Crit Care 12: 167-170 [Full Text]  
• O'Brien, G., Maurer, M. S., Taegtmeyer, H., Wilson, C. R., Dart, R. A., Jenny-Avital, E. R., Kenchaiah, S., Levy, D., Vasan, R. S., Massie, B. M. (2002). Obesity and the Risk of Heart Failure. NEJM 347: 1887-1889 [Full Text]  
• Krentz, A. J (2002). Type 2 diabetes and atherosclerotic cardiovascular disease: do they share common antecedents?. British Journal of Diabetes & Vascular Disease 2: 370-378 [Abstract]